Imlifidase in Living Donor Renal Transplantation Highly Sensitized Recipients

NCT06461546 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Inability to provide study drug to participants

Conditions

Kidney Transplant Candidates

Interventions

DRUG: Imlifidase

Sponsor

Fundacion Clinic per a la Recerca Biomédica